Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 27;9(2):e90252.
doi: 10.1371/journal.pone.0090252. eCollection 2014.

Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells

Affiliations

Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells

Regina Clare Meyer Whitemarsh et al. PLoS One. .

Abstract

Botulinum neurotoxins (BoNTs) are the most poisonous substances known and cause the severe disease botulism. BoNTs have also been remarkably effective as therapeutics in treating many neuronal and neuromuscular disorders. One of the hallmarks of BoNTs, particularly serotype A, is its long persistence of 2-6 months in patients at concentrations as low as fM or pM. The mechanisms for this persistence are currently unclear. In this study we determined the persistence of the BoNT/A subtypes 1 through 5 in primary rat spinal neurons. Remarkably, the duration of intracellular enzymatic activity of BoNT/A1, /A2, /A4 and /A5 was shown to be at least 10 months. Conversely, the effects of BoNT/A3 were observed for up to ∼5 months. An intermittent dosing with BoNT/E showed intracellular activity of the shorter acting BoNT/E for 2-3 weeks, followed by reoccurrence and persistence of BoNT/A-induced SNAP-25 cleavage products.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Recovery of SNAP-25 after exposure to BoNT/A subtypes.
Primary rat spinal cord (RSC) cells were exposed individually to sufficient concentrations of the BoNT/A subtypes 1 through 5 to generate ∼100% cleavage of SNAP-25 after 48 h. Excess toxin was aspirated and cells were washed to remove any remaining extracellular toxin. Cells lysates were collected at the time points specified and were analyzed for SNAP-25 cleavage by Western blot, and a representative blot is shown (A). Data from 4 Western blots were quantified by densitometry, and data plots generated using PRISM software (B).
Figure 2
Figure 2. Secondary intoxication with BoNT/E to monitor persistence of BoNT/A light chain activity.
Primary rat spinal cord (RSC) cells that had been exposed to BoNT/A1, /A2, /A4, and /A5 and maintained for 9 months were exposed to 10 U/50 µL of BoNT/E, a sufficient concentration of toxin to cleave ∼100% of both uncleaved SNAP-25 and SNAP-25A after 48 h. Excess toxin was aspirated and cells were washed to remove any remaining extracellular toxin. Cells lysates were collected at the time points specified and analyzed for SNAP-25 cleavage by Western blot. A representative Western blot is shown (A). Data from 4 Western blots were quantified by densitometry, and a graph showing the percentage of SNAP-25A before and 30 days after BoNT/E exposure (when no SNAP-25E remained) was generated using PRISM software (B).
Figure 3
Figure 3. Sensitivity of RSC cells cultured for 10 months to BoNT/A1 after 48 h exposure.
Cells were exposed to the indicated concentrations of BoNT/A1 and cell lysates were analyzed for SNAP-25 cleavage by Western blotting. Data from three Western blots were quantified by densitometry, and data plot and an EC50 were generated.

Similar articles

Cited by

References

    1. Smith LD, Sugiyama H (1988) Botulism: The Organism, Its Toxins, The Disease. Springfield, IL: Charles C. Thomas.
    1. Dressler D (2012) Clinical applications of botulinum toxin. Curr Opin Microbiol. England. pp. 325–336. - PubMed
    1. Schantz EJ, Johnson EA (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiological reviews 56: 80–99. - PMC - PubMed
    1. Gimenez DF, Gimenez JA (1995) The typing of botulinal neurotoxins. International journal of food microbiology 27: 1–9. - PubMed
    1. Barash JR, Arnon SS (2014) A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins. J Infect Dis 209: 183–191. - PubMed

Publication types

Substances